We propose that tumor T cell-inflammation predicted by increased expression of the c-Score is mediated by mechanisms specific to histological tumor types and their microenvironments, which include the interplay between the immunosuppressive properties of KRAS mutations with the immune stimuli resulting from DNA repair deficiencies characterized by elevated TMB and neoantigen tumor loads. The gene discussed is KRAS; the disease is neoplasm.